LILLY-F1J-MC-HMCQ

Study Sponsor: Lilly

Study Title

Duloxetine Versus Venlafaxine Extended Release in the Treatment of Major
Depressive Disorder

Medicine or Vaccine (generic name)

Duloxetine hydrochloride

Sponsor Identification Number

F1J-MC-HMCQ

Trial Registry Identification Number(#'s)

NCT00067912

Medical Condition

Major Depressive Disorder

Phase

Phase 4

Link to study details on the Lilly Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Not available

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

August 2014